Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00248170 · OUTCOME

Percentage of Participants Who Experienced Clinical Fracture Events

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer · Source last updated 2016-04-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of participants
Interval / dispersion
Not reported
Time frame
84 months

What was measured

The incidence of clinical fractures was analyzed.

Analysis population: Safety Set: The safety set included randomized participants who received at least one of study medication and had at least one post baseline assessment.

Groups in this outcome

Letrozole

2.5 mg by mouth (p.o.) once daily

Anastrozole

1 mg p.o. once daily

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Letrozole2049
Anastrozole2062

Reported measurements

Source class 1
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Letrozole9.3Not reportedNot reportedNot reportedNot reported
Anastrozole8.1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        9.3
      2. group Id
        OG001
        value
        8.1
denoms
  1. counts
    1. group Id
      OG000
      value
      2049
    2. group Id
      OG001
      value
      2062
    units
    Participants
description
The incidence of clinical fractures was analyzed.
groups
  1. description
    2.5 mg by mouth (p.o.) once daily
    id
    OG000
    title
    Letrozole
  2. description
    1 mg p.o. once daily
    id
    OG001
    title
    Anastrozole
param Type
NUMBER
population Description
Safety Set: The safety set included randomized participants who received at least one of study medication and had at least one post baseline assessment.
reporting Status
POSTED
time Frame
84 months
title
Percentage of Participants Who Experienced Clinical Fracture Events
type
SECONDARY
unit Of Measure
Percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice